Document is current
Any future updates will be listed below
-
Authors
Aicher, Helena D. https://orcid.org/0000-0001-5915-7086
Dornbierer, Joëlle https://orcid.org/0009-0006-6902-7182
Caflisch, Luzia https://orcid.org/0009-0004-6813-8986
Suay, Dila https://orcid.org/0000-0002-5268-9992
Mueller, Michael J. https://orcid.org/0000-0002-9774-9805
Landolt, Hans-Peter https://orcid.org/0000-0003-0887-9403
Quednow, Boris B. https://orcid.org/0000-0001-7933-2865
Scheidegger, Milan https://orcid.org/0000-0003-1313-2208
Dornbierer, Dario https://orcid.org/0000-0001-9946-2069
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 3 May 2026
Accepted: 23 June 2026
First Online: 14 July 2026
Declarations
:
: HDA, JD, LC, DS, HPL and BQ declare that they have no conflict of interest related to this article. DAD and MS declare that they co-founded Reconnect Labs, an academic spin-off at the University of Zurich, focused on the development of psychedelic medicines for mental health, MJM declares that he owns shares of Reconnect Labs.
: The study was conducted according to the World Medical Association Declaration of Helsinki. The study was approved by the Cantonal Ethics Committee of the Canton of Zurich (Basec-Nr. 2018-01385) and Swiss Federal Office of Public Health (BAG-Nr. (AB)-8/5-BetmG-2019/008014).
: Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects. https://clinicaltrials.gov/ct2/show/NCT04716335
